Aubagio (oh-BAH-gee-oh, teriflunomide), the third ORAL option for relapsing forms of multiple sclerosis (MS)

You'll hear about Aubagio (oh-BAH-gee-oh, teriflunomide), the third ORAL option for relapsing forms of multiple sclerosis (MS).

It's not a completely new drug.

It's the active metabolite of leflunomide (Arava, etc)...the immunomodulator used to slow progression of rheumatoid arthritis.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote